The results suggested that the expression levels of RUNDC3A-AS1 in thyroid cancer tissues and cell lines were positively correlated with ADAM9 expression (Figure 5G), while the expression levels of miR-182-5p were negatively correlated with ADAM9 expression (Figure 5H). This evidence concerns the gene ADAM9 and thyroid gland carcinoma.